CD46: Expanding beyond complement regulation

Rebecca C. Riley-Vargas, Darcy B. Gill, Claudia Kemper, M. Kathryn Liszewski, John P. Atkinson

140 Citations (Scopus)


During the 1980s CD46 was discovered in a search for C3b binding proteins of human peripheral blood cells. Its role as an inactivator of C3b and C4b deposited on self-tissue is highlighted by the observation that partial deficiency of CD46 is a predisposing factor to hemolytic uremic syndrome. This discovery has an impact on the treatment options for these patients. Other new findings have expanded the role of CD46 in immunity and disease. For example, signaling through CD46 on human T lymphocytes drives them to become regulatory cells, indicating a novel link between the complement system and cellular immunity. Also, CD46 interacts with at least seven human pathogens and participates in reproduction/fertilization, further suggesting that dissecting its multi-faceted activities will have important clinical implications.

Original languageEnglish
JournalTrends in Immunology
Issue number9
Pages (from-to)496-503
Number of pages8
Publication statusPublished - 09.2004

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'CD46: Expanding beyond complement regulation'. Together they form a unique fingerprint.

Cite this